First Three Patients with T1D Successfully Transplanted with Novel Antibody to Eliminate Harsh Anti-rejection Drug
Stunning Results of First Human Trials Presented Today in Boston at 5th Summit on Stem Cell Derived Islets MIAMI, FL, UNITED STATES, October 29, 2024 /EINPresswire.com/ — The Cure Alliance, a 501(c)(3) nonprofit, is excited to announce that three patients with type 1...
Founder’s letter to our Cure Alliance friends
Dear Friends, In recent years, The Cure Alliance (TCA) has proudly contributed to clinical trials of stem cell infusions (MSC) in severe COVID-19, and in chronic kidney disease (CKD), providing critically important information on the safety, efficacy, and mechanism of...
The Cure Alliance-funded clinical trial to silence deadliest pancreatic cancer begins recruiting patients today
Miami/September 29, 2023/A phase II clinical trial hoping to silence the deadliest form of pancreatic cancer has started enrolling patients at SUNY Downstate Medical Center in Brooklyn, N.Y., The Cure Alliance announced today. Pancreatic Ductal Adenocarcinoma Cancer...
The Cure Alliance Gets IRB Approval for “C3” Clinical Trial To Treat Deadliest Pancreatic Cancer AT SUNY Downstate
C3," a Combination of 3 Generic Drugs Designed to Halt Advanced Adenocarcinoma Pancreatic Cancer Moves from the Lab to Human Trials MIAMI, FLORIDA, UNITED STATES, July 4, 2023/EINPresswire.com/ -- The Cure Alliance, 501(c)(3) non-profit, announced today State...
Pancreatic Cancer has a New Formidable Foe — A Letter from the President of The Cure Alliance
Eureka. In the FDA’s own library, Dr. F. Charles Brunicardi and his team found a combination of three non-toxic widely used drugs that, when combined, actually turn off tumor-based pancreatic cancer.
Boca Student Pledges Bar Mitzvah Fund To The Cure Alliance
David Hain, 12, of Boca Raton, Florida announced to friends and family he will work to raise funds for The Cure Alliance as part of his year-long community service to commemorate becoming a bar mitzvah. David is a seventh grade gifted student in Loggers' Run Middle...
Watch: Dr. Camillo Ricordi talks about the use of stem cells to treat severely sick COVID-19 patients
Watch this report from 7News Miami as our very own Dr. Camillo Ricordi talks about the use of stem cells in treating those with the most severe cases of COVID-19. Video: 7News Miami
Planning Begins For Phase II Trial Of UC-MSC For Most Severe COVID-19 Cases
The Cure Alliance announces the start of planning for phase II of the clinical trial of umbilical cord-derived mesenchymal stem cells (UC-MSCs) to block the life-threatening lung inflammation IN COVID-19.
Watch MSNBC: Major Med Centers join Cure Alliance in UC MSC Therapy
Continuing his rounds on TV, our Dr. Camillo Ricordi appeared on MSNBC's Kasie DC Sunday. Watch his one-on-one interview above. Video: MSNBC
1st UC-MSC Infusion given to gravely ill COVID-19 patient ahead of Miami clinical trial
Our very own Dr. Camillo Ricordi recently appeared on News4Jax's The Morning Show to discuss clinical trials on a new method given to gravely ill Covid-19 patients. Watch the video above. Video: News4Jax